Considerations in boosting COVID-19 vaccine immune responses
| Errataetall: |
CommentIn: Lancet. 2022 Mar 26;399(10331):1224. - PMID 35339219 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:398 |
|---|---|
| Enthalten in: |
Lancet (London, England) - 398(2021), 10308 vom: 09. Okt., Seite 1377-1380 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Krause, Philip R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 Vaccines |
|---|
| Anmerkungen: |
Date Completed 18.10.2021 Date Revised 31.12.2022 published: Print-Electronic CommentIn: Lancet. 2022 Mar 26;399(10331):1224. - PMID 35339219 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S0140-6736(21)02046-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330764772 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330764772 | ||
| 003 | DE-627 | ||
| 005 | 20231225212003.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(21)02046-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1102.xml |
| 035 | |a (DE-627)NLM330764772 | ||
| 035 | |a (NLM)34534516 | ||
| 035 | |a (PII)S0140-6736(21)02046-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Krause, Philip R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Considerations in boosting COVID-19 vaccine immune responses |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.10.2021 | ||
| 500 | |a Date Revised 31.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Lancet. 2022 Mar 26;399(10331):1224. - PMID 35339219 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Fleming, Thomas R |e verfasserin |4 aut | |
| 700 | 1 | |a Peto, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Longini, Ira M |e verfasserin |4 aut | |
| 700 | 1 | |a Figueroa, J Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Sterne, Jonathan A C |e verfasserin |4 aut | |
| 700 | 1 | |a Cravioto, Alejandro |e verfasserin |4 aut | |
| 700 | 1 | |a Rees, Helen |e verfasserin |4 aut | |
| 700 | 1 | |a Higgins, Julian P T |e verfasserin |4 aut | |
| 700 | 1 | |a Boutron, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Pan, Hongchao |e verfasserin |4 aut | |
| 700 | 1 | |a Gruber, Marion F |e verfasserin |4 aut | |
| 700 | 1 | |a Arora, Narendra |e verfasserin |4 aut | |
| 700 | 1 | |a Kazi, Fatema |e verfasserin |4 aut | |
| 700 | 1 | |a Gaspar, Rogerio |e verfasserin |4 aut | |
| 700 | 1 | |a Swaminathan, Soumya |e verfasserin |4 aut | |
| 700 | 1 | |a Ryan, Michael J |e verfasserin |4 aut | |
| 700 | 1 | |a Henao-Restrepo, Ana-Maria |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 398(2021), 10308 vom: 09. Okt., Seite 1377-1380 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
| 773 | 1 | 8 | |g volume:398 |g year:2021 |g number:10308 |g day:09 |g month:10 |g pages:1377-1380 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S0140-6736(21)02046-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 398 |j 2021 |e 10308 |b 09 |c 10 |h 1377-1380 | ||